Anaplastic lymphoma kinase ( ALK ) rearrangements were first identified as an oncogenic driver in non-small cell lung cancers (NSCLC) in 2007, specifically the gene re-arrangement between ALK and echinoderm microtubule-associated protein like 4 ( EML4 ) (1).
No takes yet. Share an insight, caveat, or question.
Lockney et al. (2017) studied this question.